Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-335 and Odalasvir +/- Simeprevir in HCV
NCT02569710Phase 2Completed
- Sponsor
- Alios BioPharma
- Start
- Oct 2015
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of adafosbuvir, odalasvir in hepatitis C (HCV), sponsored by Alios BioPharma. Started Oct 2015; status: completed.
02
Drugs
adafosbuvirodalasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02569710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02569710.